Answers are grounded in this paper and cite their sources.
miR-145 is dysregulated in mouse models of PAH. Downregulation of miR-145 protects against the development of PAH. In patient samples of heritable PAH and idiopathic PAH, miR-145 is expressed in remodeled vessels and mutations in BMPR2 lead to upregulation of miR-145 in mice and PAH patients. Manipulation of miR-145 may represent a novel strategy in PAH treatment.
No takes yet. Share an insight, caveat, or question.
Caruso et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: